Oxford Nanopore to Present at Barclays Conference

Oxford Nanopore Technologies plc

12 March 2024

 

Oxford Nanopore Technologies plc

Oxford Nanopore to Present at the Barclays 26^th Annual Global Healthcare Conference

12 March 2024

Oxford Nanopore Technologies plc (LSE: ONT) ("Oxford Nanopore"), the company delivering a new generation of nanopore-based molecular sensing technology, will participate in the Barclays 26th Annual Global Healthcare Conference today, 12 March 2024, in Miami, FL.

Gordon Sanghera, Chief Executive Officer, and Nick Keher, Chief Financial Officer, will participate in an analyst led fireside chat at 9:00am EDT (1:00pm GMT).

A live webcast of the presentation can be accessed at the company's investor relations page at: https://nanoporetech.com/about-us/investors/reports. A replay will be available for at least 30 days following the event via the same link.

[ENDS]

For further information, please contact:

Oxford Nanopore Technologies plc

Investors:          [e-mail]

Media:              [e-mail]

Teneo (communications adviser to the Company)

Tom Murray, Olivia Peters

[phone]

[e-mail]

About Oxford Nanopore Technologies plc:

Oxford Nanopore Technologies' goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The company has developed a new generation of nanopore-based sensing technology that is currently used for real-time, high-performance, accessible, and scalable analysis of DNA and RNA.  The technology is used in more than 120 countries, to understand the biology of humans, plants, animals, bacteria, viruses and environments as well as to understand diseases such as cancer.  Oxford Nanopore's technology also has the potential to provide broad, high impact, rapid insights in a number of areas including healthcare, food and agriculture. 

For more information please visit: www.nanoporetech.com

 

END